Hypertension and the eye

Current Hypertension Reports

Volumn 4, Issue 6, 2002, Pages 471-476

  Wolffsohn, James S ^a   Hurcomb, Peter G ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; EYE; HUMAN; INTRAOCULAR HYPERTENSION; MORBIDITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA BLOOD VESSEL; REVIEW; VASCULARIZATION;

BLOOD PRESSURE; EYE; HUMANS; MORBIDITY; OCULAR HYPERTENSION; RETINAL VESSELS;

EID: 0036886728     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-002-0028-z     Document Type: Article

References (50)

1. Black HR, Kuller LH, O'Rourke MF, et al.: The first report of the systolic and pulse pressure (SYPP) working group. J Hypertens 1999, 17:(Suppl 5)S3-S14.
2. Hayreh SS: Duke-Elder lecture: systemic arterial blood pressure and the eye. Eye 1996, 10: 5-28.
3. Harris MG, Gan CM, Revelli EJ, et al.: Blood pressure measurement by eye care practitioners. J Am Optom Assoc 1994, 65: 512-516.
4. Tso OM, Jampol LM: Pathophysiology of hypertensive retinopathy. Ophthalmol 1982, 89: 1132-1145.
5. Kishi S, Tse MOM, Hayreh SS: Fundus lesions in malignant hypertension. I. A pathologic study of experimental hypertensive choroidopathy. Arch Ophthalmol 1985, 103: 1189-1206.
6. Hayreh SS, Servais GE, Virdi PS: Fundus lesions in malignant hypertension V. Hypertensive optic neuropathy. Ophthalmol 1986, 93: 74-87.
7. Dodson PM, Kritzinger EE: Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997? Eye 1997, 11: 3-11.
8. Dodson PM, Kritzinger EE: Management of retinal vein occlusion. BMJ 1987, 295: 1434-1435.
9. Hayreh SS, Zimmermann MB, Podhajsky P: Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994, 10 3: 429-441.
10. Hankey GJ, Slattery JM, Warlow CP: Prognosis and prognostic factors of retinal infarction: a prospective cohort study. BMJ 1991, 302: 499-504.
11. Walsh JB: Hypertensive retinopathy. Description, classification, and prognosis. Ophthalmol 1982, 89: 1127-1131.
12. Keith NM, Wagener HP, Barker NW: Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939, 191: 332-343.
13. Bechgaard P, Porsaa K, Vogelius H: Ophthalmological investigations of 500 persons with hypertension of long duration. Br J Ophthalmol 1950, 34: 409-424.
14. Aurell E, Tibblin G: Hypertensive eye-ground changes in a Swedish population of middle-aged men. Acta Ophthalmol 1965, 43: 355-361.
15. Stokoe NL, Turner RWD: Normal retinal vascular patterns. Br J Ophthalmol 1966, 50: 21-40.
16. Hayreh SS: Classification of hypertensive fundus changes and their order of appearance. Ophthalmologica 1989, 198: 247-260.
17. McGregor E, Isles C, Jay JL, et al.: Retinal changes in malignant hypertension. BMJ 1986, 292: 233-234.
18. Scheie HG: Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis. AMA Arch Ophthalmol 1953, 49: 117-138.
19. Leishman R: The eye in general vascular disease: hypertension and arteriosclerosis. Br J Ophthalmol 1957, 41: 641-701.
20. Cogan DG: Ophthalmic manifestations of systemic vascular diseases. In Major Problems in Internal Medicine. Edited by Smith LH. Philadelphia: WB Saunders; 1974: 74-80.
21. Dodson PM, Lip SM, Gibson JM, Beevers DG: Hypertensive retinopathy: a review of existing classification systems and a suggestion for a simplified grading system. J Hum Hypertens 1996, 10: 93-98.
22. Augsburger AR, Good GW: Hypertension: an optometric problem for the 80s. J Am Optom Assoc 1986, 57: 355-359.
23. Svardsudd K, Wedel H, Aurell E, Tibblin G: Hypertensive eye ground changes: prevalence, relation to blood pressure, and prognostic importance. Acta Med Scand 1978, 204: 159-167.
24. Wolffsohn JS, Napper GA, Ho S-M, et al.: Improving the Description of the Retinal Vasculature and Patient History Taking for Monitoring Systemic Hypertension. Ophthal Physiol Opt 2001, 21: 441-449.
25. Dimmitt SB, Eames SM, Goslin P, et al.: Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet 1989, 1: 1103-1106.
26. Rassam SM, Patel V, Kohner EM: The effect of acetazolamide on the retinal circulation. Eye 1993, 7: 697-702.
27. Kergoat H, Lovaski JV: Response of parapapillary retinal vessels to exercise. Optom Vis Sci 1995, 72: 249-257.
28. Sugiyama T, Schwartz B, Takamoto T, Azuma I: Evaluation of the circulation in the retina, peripapillary choroid and optic disk in normal-tension glaucoma. Ophthalmic Res 2000, 32: 79-86.
29. Chen HC, Patel V, Wiek J, et al.: Vessel diameter changes during the cardiac cycle. Eye 1994, 8: 97-103.
30. Houben AJ, Canoy MC, Paling HA, et al.: Quantitative analysis of retinal vascular changes in essential and renovascular hypertension. J Hypertens 1995, 13: 1729-1733.
31. Wolf S, Werner E, Schulte K, Reim M: Acute effect of metipranolol on the retinal circulation. Br J Ophthalmol 1998, 82: 892-896.
32. Hubbard LD, Brothers RJ, King WN, et al.: Methods for evaluation of retinal microvascular abnormalities associated with hypertension / sclerosis in the atherosclerosis risk in communities study. Ophthalmol 1999, 106: 2269-2280.
33. Williams TD: Quantification of arteriolar tortuosity in two normotensives age groups. Am J Optom Physiol Optics 1982, 59: 675-679.
34. Hart WE, Goldbaum M, Cote B, et al.: Measurement and classification of retinal vascular tortuosity. Int J Med Inf ect 1999, 53: 239-252.
35. Wallow IH, Bindley CD, Reboussin DM, et al.: Systemic hypertension produces pericyte changes in retinal capillaries. Invest Ophthalmol Vis Sci 1993, 34: 420-430.
36. Marshall EC, Malinovsky VE: Hypertension and the eye: applications of the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. J Am Optom Assoc 1998, 69: 281-291.
37. Klein R, Klein BEK, Moss SE, Wang Q: Blood pressure, hypertension and retinopathy in a population. Trans Am Ophthalmol Soc 1993, 9: 207-222.
38. Klein R, Klein BEK, Moss SE, Wang Q: Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol 1994, 112: 92-98.
39. Hurcomb PG, Wolffsohn JS, Napper GA: Ocular signs of systemic hypertension: a review. Ophthal Physiol Opt 2001, 2: 430-440.
40. Salus R: Diagnosis of arteriosclerosis and hypertension. Am J Ophthalmol 1958, 45: 81-92.
41. Breslin DJ, Gifford RW, Fairbairn JF, Kearns TP: Prognostic importance of ophthalmoscopic findings in essential hypertension. JAMA 1966, 195: 335-338.
42. Klein R, Klein BEK, Moss SE: The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 1997, 95: 329-350.
43. Wong TY, Klein R, Couper LS, et al.: Retinal microvascular abnormalities and incident stroke: the atherosclerosis risk in communities study. Lancet 2001, 358: 1134-1140.
44. Hayreh SS, Servais GE, Virdi PS: Fundus lesions in malignant hypertension IV Focal intraretinal periarteriolar transudates. Ophthalmol 1986, 93: 60-73.
45. Stokoe NL: Clinical assessment of the hypertensive fundus. Trans Ophthalmol Soc 1975, 95: 463-471.
46. Hayreh SS, Servais GE, Virdi PS: Cotton wool spots (inner retinal ischaemic spots) in malignant hypertension. Ophthalmologic 1989, 198: 197-215.
47. Hayreh SS, Servais GE, Virdi PS: Fundus lesions in malignant hypertension VI. Hypertensive choroidopathy. Ophthalmol 1986, 93: 1383-1400.
48. Klein R: Retinopathy in a population-based study. Trans Am Ophthalmol Soc 1992, 90: 561-594.
49. Yu T, Mitchell P, Berry G, et al.: Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 1998, 116: 83-89.
50. Leibowitz HM, Krueger DE, Maunder LR, et al.: The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980, 24(Suppl): 335-610.